Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.15    
    

AMENDMENT NO. 1 TO

WATSON PHARMACEUTICALS, INC.

KEY EMPLOYEE AGREEMENT  

        WHEREAS, Watson Pharmaceuticals, Inc. (the "Company") and James Nash ("the Executive") have entered into
the Key Employee Agreement dated as of August 16, 2004 (the "Agreement"); and, 

        WHEREAS, the Supply Chain organization of the Company has recently been renamed "Technical Operations" in order to more clearly identify
its function and mission both within and outside of the Company; and, 

        WHEREAS, the Company and the Executive wish to amend the Agreement to reflect the foregoing change. 

        NOW, THEREFORE, the Agreement is hereby amended as follows: 

        The
first sentence of Section 1 of the Agreement is amended in its entirety to read: 

        1.    EMPLOYMENT BY THE COMPANY.    Subject to terms set forth herein, the Company agrees to employ Executive in the
position of Executive Vice President, Technical Operations, and Executive hereby accepts employment effective as of the Effective Date. 

        Except
as specifically amended by this Amendment No. 1, all terms and conditions of the Agreement remain in full force and effect. 

        IN WITNESS WHEREOF, the Company and the Executive have executed this Amendment No. 1 effective as of December 13, 2004. 

	WATSON PHARMACEUTICALS, INC.	 	EXECUTIVE
	

By:	
/s/  SUSAN K. SKARA      
 Susan K. Skara

Sr. Vice President, Human Resources

Date: December 16, 2004	
 	
/s/  JAMES NASH      
 Name: James Nash

Date: December 14, 2004

QuickLinks

Exhibit 10.15QuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 10.16    
    

Watson Pharmaceuticals, Inc.
  2001 INCENTIVE AWARD PLAN

NOTICE OF GRANT AND SIGNATURE PAGE  

        Congratulations, you ("Holder") have been granted an option to purchase Common Stock of Watson Pharmaceuticals, Inc., a Nevada corporation (the "Company").
The Option is subject to the terms and conditions of the Award Agreement and the 2001 Incentive Award Plan of the Company, as amended from time to time (the "Plan"), which are attached hereto as
Exhibit 1-A and 1-B, and of which this Notice of Grant and Signature Page is a part. By signing this Notice of Grant and Signature Page, you represent and warrant to the
Company that you have read the Award Agreement and the Plan and agree to be bound by their terms. Capitalized terms not otherwise defined in this Notice of Grant and Signature Page shall be as defined
in the Plan and the Award Agreement. 

        Subject
to the terms of the Award Agreement and the Plan, the terms of this Option are set forth below: 

	Type of Option: Incentive Stock Option	 	 	Non-Qualified Stock Option	 
	 	
	 	 	

	Holder's Name: [First Name and Last Name]	 	Total Number of Option Shares:	 
	 	 	 	 	

	Date of Grant: [Month, Day, Year]	 	 	Purchase Price Per Share:	$

        Subject
to the terms of the Award Agreement and the Plan, this Option shall become exercisable in accordance with the following schedule: 

	On and After This Date
 
	 	This Option Shall be Exercisable With Respect to

the Following Number of Shares in Each Period

Becoming Fully Vested on the Date Shown.

	Month, Day, Year	 	Number
	Month, Day, Year	 	Number
	Month, Day, Year	 	Number
	Month, Day, Year	 	Number
	Month, Day, Year	 	Number
	 	 	

	 	Total Shares	 	Total

NOTE, schedule does not reflect cumulative vesting.

        IN
WITNESS WHEREOF, the Company has granted this Option, subject to the terms set forth herein, on the date of grant specified above. 

	 	 	WATSON PHARMACEUTICALS, INC.
	

 	
 	

 
	 	 	
 Allen Chao, Ph.D.,

Chairman and Chief Executive Officer
	ACCEPTED:	 	 
	

 	
 	

 
	
 Holder's Signature	 	 
	

 	
 	

 
	
	 	 
	

 	
 	

 
	
 Address	 	 
	

 	
 	

 
	
 Holder's Taxpayer Identification Number	 	

GRANT NO: 0000XXXX
	

 	
 	
Note: This document constitutes the Company's offer to enter into an agreement under the terms set forth herein. This offer will expire without further notice at 5 o'clock Pacific Time
sixty days after the date of grant of the Option set forth above, unless this offer is accepted by Holder by the delivery of this original Notice of Grant and Signature Page, executed by Holder to the Company on or prior to the offer's
expiration date.

 
EXHIBIT 1-A  

 AWARD AGREEMENT  

        THIS AWARD AGREEMENT, dated as of the Date of Grant appearing on the Notice of Grant and Signature Page hereof, is made by and between Watson
Pharmaceuticals, Inc., a Nevada corporation (the "Company"), and the Employee or Consultant whose name and signature appear on the Notice of Grant and Signature Page hereof (the "Holder"). 

        WHEREAS,
the Company wishes to grant the Holder an option (the "Option") to purchase shares of its common stock, par value $.0033 per share (the "Common Stock"), pursuant to the terms of
the Notice of Grant and Signature Page, this Agreement and the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc., as amended from time to time (the terms of which are hereby
incorporated by reference and made a part of this Agreement, the "Plan"); and 

        WHEREAS,
it has been determined that it would be to the advantage and best interest of the Company and its stockholders to grant Holder the Option as an inducement to enter into or
remain in
the service of the Company or its Subsidiaries and as an incentive for increased efforts during such service. 

        NOW,
THEREFORE, in consideration of the mutual covenants herein contained and other good and valuable consideration, receipt of which is hereby acknowledged, the parties hereto do hereby
agree as follows: 

ARTICLE I
 GRANT OF OPTION

        Section 1.1—Grant of Option and Purchase Price.    The
Company grants to Holder the option to purchase any part or all of an aggregate of that many shares of Common Stock as set forth on the Notice of Grant and Signature Page hereto, upon the terms and
conditions set forth in this Agreement. The per share purchase price of the shares of Common Stock covered by the Option shall be as set forth on the Notice of Grant and Signature Page hereto, without
commission or other charge. 

        Section 1.2—Consideration to Company.    In consideration of
the granting of this Option by the Company, the Holder agrees to render faithful and efficient services to the Company or a Subsidiary, with such duties and responsibilities as the Company shall from
time to time prescribe, for a period of at least one (1) year from the date this Option is granted. Nothing in this Agreement or in the Plan shall confer upon the Holder any right to continue
in the employ or engagement of the Company or any Subsidiary, or shall interfere with or restrict in any way the rights of the Company and its Subsidiaries, which are hereby expressly reserved, to
discharge or terminate the engagement with the Holder at any time for any reason whatsoever, with or without Cause. 

ARTICLE II
 PERIOD OF EXERCISABILITY

        Section 2.1—Exercisability.    Subject to Section 2.2,
Section 4.5 and the terms of any written agreement between the Company and the Holder relating to the exercisability of the Option, the Option shall become exercisable as set forth in the
Notice of Grant and Signature Page hereto. No portion of the Option which is unexercisable at Termination of Consultancy or Termination of Employment, as applicable, shall thereafter become
exercisable. Each such installment which becomes exercisable pursuant to this Section 2.1 shall remain exercisable until it becomes unexercisable under Section 2.2 or the Plan. 

1

 

        Section 2.2—Expiration of Option.    The Option may not be
exercised to any extent by anyone after the first to occur of the following events: 

        (a)   The
expiration of ten (10) years from the date the Option was granted; 

        (b)   Except
in the case of the Holder's disability (within the meaning of Section 22(e)(3) of the Code) or as set forth in Sections 2.2(d) and (e), the expiration of
three (3) months from the date of the Holder's Termination of Consultancy or Termination of Employment, as applicable, unless the Holder dies within said three month period; 

        (c)   In
the case of the Holder's disability (within the meaning of Section 22(e)(3) of the Code), the expiration of one (1) year from the date of the Holder's
Termination of Consultancy or Termination of Employment, as applicable, by reason of the Holder's disability; 

        (d)   The
expiration of one (1) year from the date of the Holder's death; or 

        (e)   Upon
Holder's Termination of Consultancy or Termination of Employment, as applicable, by the Company or a Subsidiary of the Company for Cause, at the discretion of the
Committee effective upon written notice to the Holder. 

        Section 2.3—Special Tax Consequences.    The Holder
acknowledges that, to the extent that the aggregate Fair Market Value of stock with respect to which "incentive stock options" (within the meaning of Section 422 of the Code, but without regard
to Section 422(d) of the Code), including the Option, are exercisable for the first time by the Holder during any calendar year under the Plan and all other incentive stock option plans of the
Company, any Subsidiary and any parent corporation thereof (within the meaning of Section 422 of the Code)) exceeds $100,000, such options shall not be treated as "incentive stock options" to
the extent required by Section 422 of the Code. The Holder further acknowledges that the rule set forth in the preceding sentence shall be applied by taking options into account in the order in
which they were granted. For purposes of these rules, the Fair Market Value of stock shall be determined as of the time the option with respect to such stock is granted. 

ARTICLE III
 EXERCISE OF OPTION

        Section 3.1—Person Eligible to Exercise.    During the
lifetime of the Holder, only Holder may exercise the Option or any portion thereof. After the death of Holder, any exercisable portion of the
Option may, prior to the time when the Option becomes unexercisable under Section 2.2 or the Plan, be exercised by Holder's personal representative or by any person empowered to do so under the
deceased Holder's will or under the then applicable laws of descent and distribution. 

        Section 3.2—Partial Exercise.    Any exercisable portion of
the Option or the entire Option, if then wholly exercisable, may be exercised in whole or in part as to whole shares only at any time prior to the time when the Option or portion thereof becomes
unexercisable under Section 2.2 or the Plan. 

        Section 3.3—Manner of Exercise.    The Option, or any
exercisable portion thereof, may be exercised solely by delivery to the Secretary of the Company, or such other person or entity designated by the Committee, or his, her or its office, as applicable,
of all of the following prior to the time when the Option or such portion becomes unexercisable under Section 2.2 or the Plan: 

        (a)   A
written notice complying with the applicable rules established by the Committee stating that the Option, or a portion thereof, is exercised. The notice shall be signed
by the Holder or other person then entitled to exercise the Option or such portion; and 

        (b)   (i) Full
cash payment to the Secretary of the Company for the shares with respect to which such Option or portion is exercised; 

2

 

        (ii)   With
the consent of the Committee (which consent may be withheld in its sole and absolute discretion), (A) shares of the Company's Common Stock owned by the
Holder, duly endorsed for transfer to the Company, with a Fair Market Value on the date of delivery equal to the aggregate exercise price of the Option or exercised portion thereof, or
(B) shares of the Company's Common Stock issuable to the Holder upon exercise of the Option, with a Fair Market Value on the date of delivery equal to the aggregate exercise price of the Option
or exercised portion thereof; 

        (iii)  With
the consent of the Committee (which consent may be withheld in its sole and absolute discretion), a notice that the Holder has placed a market sell order with a
broker with respect to shares of the Company's Common Stock then issuable upon exercise of the Option, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale
to the Company in satisfaction of the Option exercise price; or 

        (iv)  With
the consent of the Committee (which consent may be withheld in its sole and absolute discretion), any combination of the consideration provided in the foregoing
subparagraphs (i), (ii) and (iii); and 

        (c)   Full
payment to the Company (or other employer corporation) of all amounts which, under federal, state or local tax law, it is required to withhold upon exercise of the
Option. With the consent of the Committee (which consent may be withheld in its sole and absolute discretion), all or part of such payment may be made in the form of (i) shares of the Company's
Common Stock owned by Holder, duly endorsed for transfer, with a Fair Market Value equal to the sums required to be withheld, or (ii) shares of the Company's Common Stock issuable to Holder
upon exercise of the Option with a Fair Market Value equal to the sums required to be withheld; provided, that the number of shares of Common Stock
which may be withheld with respect to the issuance, vesting, exercise or payment of any Option (or which may be repurchased from the Optionee of such Option within six months after such shares of
Common Stock were acquired by the Optionee from the Company) in order to satisfy the Optionee's federal and state income and payroll tax liabilities with respect to the issuance, vesting, exercise or
payment of the Option shall be limited to the number of shares which have a Fair Market Value on the date of withholding or repurchase equal to the aggregate amount of such liabilities based on the
minimum statutory withholding rates for federal and state tax income and payroll tax purposes that are applicable to such supplemental taxable income; and 

        (d)   In
the event the Option or portion shall be exercised pursuant to Section 3.1 by any person or persons other than the Holder, appropriate proof of the right of
such person or persons to exercise the Option. 

        Section 3.4—Conditions to Issuance of Stock
Certificates.    The shares of stock deliverable upon the exercise of the Option, or any portion thereof, may be either previously authorized but unissued shares or,
to the extent applicable to the Company, issued shares which have then been reacquired by the Company. Such shares shall be fully paid and nonassessable. The Company shall not be required to issue or
deliver any certificate or certificates for shares of stock purchased upon the exercise of the Option or portion thereof prior to fulfillment of all of the following conditions: 

        (a)   The
admission of such shares to listing on all stock exchanges on which such class of stock is then listed; and 

        (b)   The
completion of any registration or other qualification of such shares under any state or federal law or under rulings or regulations of the Securities and Exchange
Commission or of any other governmental regulatory body, which the Committee shall, in its absolute discretion, deem necessary or advisable; and 

3

 

        (c)   The
obtaining of any approval or other clearance from any state or federal governmental agency which the Committee shall, in its absolute discretion, determine to be
necessary or advisable; and 

        (d)   The
lapse of such reasonable period of time following the exercise of the Option as the Committee may from time to time establish for reasons of administrative
convenience; and 

        (e)   The
receipt by the Company of full payment for such shares, including payment of all amounts which, under federal, state or local tax law, the Company (or other employer
corporation) is required to withhold upon exercise of the Option. 

        Section 3.5—Rights as Stockholder.    The Holder shall not
be, nor have any of the rights or privileges of, a stockholder of the Company in respect of any shares purchasable upon the exercise of any part of the Option unless and until certificates
representing such shares have been issued by the Company to the Holder. 

ARTICLE IV
 OTHER PROVISIONS

        Section 4.1—Administration.    The Committee shall have the
power to interpret the Plan and this Agreement, and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith, to interpret, amend or revoke
any such rules and to amend this Agreement provided that the rights or obligations of the Holder are not affected adversely. Any grant or award under the Plan need not be the same with respect to each
holder. All actions taken and all interpretations and determinations made by the Committee in good faith shall be final and binding upon the Holder, the Company and all other interested persons. No
member of the Committee shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or the Option. In its absolute discretion, the Board may
at any time and from time to time exercise any and all rights and duties of the Committee under the Plan and this Agreement except with respect to matters which under Rule 16b-3 or
Section 162(m) of the Code, or any regulations or rules issued thereunder, are required to be determined in the sole discretion of the Committee. In addition, the Committee has the authority,
in its discretion, to delegate all or any part of its responsibilities and powers under this Agreement to any person or persons selected by it. 

        Section 4.2—Option Not Transferable.    Neither the Option
nor any interest or right therein or part thereof shall be sold, pledged, assigned or transferred in any manner other than by will or the laws of descent and distribution or, subject to the consent of
the Administrator, pursuant to a DRO, unless and until the shares underlying such Option have been issued. Neither the Option nor any interest or right therein or part thereof shall be liable for the
debts, contracts or engagements of the Holder or his successors in interest or shall be subject to disposition by transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means
whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any
attempted disposition thereof shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding sentence. 

        During
the lifetime of the Holder, only he may exercise an Option (or any portion thereof) granted to him under the Plan, unless it has been disposed of with the consent of the
Administrator pursuant to a DRO. After the death of the Holder, any exercisable portion of an Option may, prior to the time when such portion becomes unexercisable under the Plan or this Agreement, be
exercised by his personal representative or by any person empowered to do so under the deceased Holder's will or under the then applicable laws of descent and distribution. 

4

 

        Section 4.3—Notices.    Any notice to be given under the
terms of this Agreement to the Company shall be addressed to the Company in care of its Secretary, and any notice to be given to the Holder shall be addressed to him at the address given beneath his
signature hereto. By a notice given pursuant to this Section 4.3, either party may hereafter designate a different address for notices to be given to him. Any notice which is required to be
given to the Holder shall, if the Holder is then deceased, be given to the Holder's personal representative if such representative has previously informed the Company of his status and address by
written notice under this Section 4.3. Any notice shall be deemed duly given when enclosed in a properly sealed envelope or wrapper addressed as aforesaid, deposited (with postage prepaid) in a
post office or branch post office regularly maintained by the United States Postal Service. 

        Section 4.4—Titles and Construction.    Titles are provided
herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. This Agreement shall be administered, interpreted and enforced under the internal laws
of the State of California, without regard to conflicts of laws thereof. 

        Section 4.5—Conformity to Securities Laws.    The Holder
acknowledges that the Plan is intended to conform to the extent necessary with all provisions of the Securities Act and the Exchange Act and any and all regulations and rules promulgated by the
Securities and Exchange Commission thereunder, including without limitation Rule 16b-3. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the
Option is granted and may be exercised, only in such a manner as to conform to such laws, rules and regulations. To the extent permitted by applicable law, the Plan and this Agreement shall be deemed
amended to the extent necessary to conform to such laws, rules and regulations. 

ARTICLE V
 DEFINITIONS

        Whenever
the following terms are used in this Agreement, they shall have the meaning specified below. The masculine pronoun shall include the feminine and neuter, and the singular the
plural, where the context so indicates. All capitalized terms used herein without definition shall have the meanings ascribed to such terms in the Plan. 

        "Cause"
shall mean the following: 

        (a)   in
the case of an Employee, (i) "Cause", as defined in the employment agreement, if any, between the Company or a Subsidiary of the Company and the Holder, as in
effect from time to time, or (ii) in the absence of such an employment agreement, as determined by the Committee in its sole discretion, (A) the Holder's conviction of, or no contest
plea to, a felony or a misdemeanor involving moral turpitude, or (B) the Holder's gross negligence or misconduct, or material violation of the Company's policies (including without limitation
the Company's policy on insider trading), or a material breach of the Holder's duties or loyalty to the Company, or (C) the Holder's fraud, embezzlement or criminal conduct that is damaging to
the Company, or (D) the Holder's willful or continued failure to substantially perform his or her duties to the Company. 

        (b)   in
the case of a Consultant, as determined by the Committee in its sole discretion, (A) the Holder's conviction of, or no contest plea to, a felony or a
misdemeanor involving moral turpitude, or (B) the Holder's gross negligence or misconduct, or material violation of the Company's policies applicable to Holder (including without limitation the
Company's policy on insider trading), or a material breach of Holder's duties to the Company (including without limitation, a material breach of the terms of any consulting agreement between the
Company and the Holder), or (C) the Holder's fraud, embezzlement or criminal conduct that is damaging to the Company, or (D) the Holder's willful or continued failure to substantially
perform his or her duties to the Company. 

5

EXHIBIT 1-B  

 2001 INCENTIVE AWARD PLAN  

QuickLinks

Exhibit 10.16

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00080-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00080-of-00352.parquet"}]]